US Broker Ratings

HUTCHMED (China) Limited (HCM) Stock Analysis: Exploring a 41.69% Potential Upside in the Healthcare Sector

HUTCHMED (China) Limited (NASDAQ: HCM) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in Hong Kong, the company is..

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis: A Potential 69.87% Upside Beckons Investors

Investors with a keen eye on the biotechnology sector may find Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) a compelling opportunity, especially with the stock’s potential upside of..

Catalyst Pharmaceuticals, Inc. (CPRX) Investor Outlook: Biotech Stock with a 70% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a prominent player in the biotechnology industry, continues to capture the attention of individual investors with its promising growth prospects and..

Belite Bio, Inc (BLTE) Stock Analysis: Eyeing a 38.87% Upside with Breakthrough Biotech Innovations

Belite Bio, Inc (NASDAQ: BLTE) stands out in the biotechnology sector, capturing the attention of investors with a promising portfolio focused on addressing unmet medical needs..

Merus N.V. (MRUS) Stock Analysis: Unveiling a 34.51% Potential Upside in the Biotech Sector

For investors scouting the dynamic landscape of biotechnology, Merus N.V. (NASDAQ: MRUS) presents a compelling narrative. Specializing in the cutting-edge field of immuno-oncology, Merus is a..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A Potential 68.55% Upside in the Medical Device Arena

Investors with an eye on the healthcare sector, particularly in medical devices, might want to take a closer look at PROCEPT BioRobotics Corporation (NASDAQ: PRCT). With..

Arcellx, Inc. (ACLX) Stock Analysis: 59% Potential Upside Ignites Investor Interest in Biotech Innovator

Arcellx, Inc. (NASDAQ: ACLX), a burgeoning player in the biotechnology sector, is drawing significant attention from investors, thanks to its promising portfolio of immunotherapies targeting cancer..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Growth Potential in the Dental Sector

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, specializes in the development and sale of dental products across the globe. With a..

Metsera, Inc. (MTSR) Stock Analysis: Exploring a 68% Upside Potential in Biotechnology

Metsera, Inc. (MTSR) has captured investor attention with its impressive 68.09% potential upside, making it a noteworthy player in the healthcare sector’s biotechnology industry. Based in..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a 24% Upside Potential in the Biotech Sector

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is capturing the attention of investors with its innovative approach in the biotechnology sector. Headquartered in Newark, California, this biopharmaceutical company..

Zai Lab Limited (ZLAB)

⚠️ No article content returned.

..

MoonLake Immunotherapeutics (MLTX): Investor Outlook Reveals 26.86% Upside Potential in Biotech Innovator

MoonLake Immunotherapeutics (NASDAQ: MLTX) is quickly capturing the attention of investors with its pioneering approach to treating inflammatory skin and joint diseases. Based in Zug, Switzerland,..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring the 18.63% Upside Potential for Savvy Investors

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) stands as a significant player within the healthcare sector, specializing in the medical instruments and supplies industry. With over a century..

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a 323% Potential Upside in Biotechnology

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors with its ambitious vision to revolutionize cancer and infectious disease therapies through innovative biotechnology. As a..

CRISPR Therapeutics AG (CRSP) Investor Outlook: Unpacking the 50% Potential Upside

CRISPR Therapeutics AG (CRSP), a pioneer in the biotechnology sector, is making significant strides with its cutting-edge gene-editing technology. As a Switzerland-based company with a market..

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook on a Biotech with 175.77% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a key player in the biotechnology sector, is capturing investor attention with its promising pipeline and significant potential upside. With a..

BrightSpring Health Services (BTSG) Stock Analysis: Navigating a Promising Upside of Nearly 19%

BrightSpring Health Services, Inc. (BTSG), a notable player in the healthcare sector, specifically within the Health Information Services industry, is capturing investor attention with its robust..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Market with a -42.65% Potential Downside

Oscar Health, Inc. (NYSE: OSCR), a trailblazer in the healthcare technology sector, continues to capture attention despite facing significant challenges. With a market capitalization of $5.02..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A High-Flying Medical Device Innovator with a Strategic Edge

Investors with an eye on the healthcare sector may find iRhythm Technologies, Inc. (IRTC) a compelling candidate. With a market capitalization of $5.82 billion, this San..

Inspire Medical Systems, Inc. (INSP): Growth Potential and Analyst Ratings Signal a Compelling 67% Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP) stands at a fascinating intersection of healthcare and technology, offering investors a unique opportunity within the medical devices industry. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds